
Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.
The FDA is holding a forum this month to address MRI safety concerns and find ways to cut incidents. Industry leaders agree there should be safety standards in place, but are mixed on whether federal regulation is needed. What do you think?
The
What do you think? Vote here and tell us more in the comments below.





